Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotics for Preventing Neratinib-Induced Diarrhea in Breast Cancer
NCT06892093Recruiting
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Aug 2025
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
Randomised, double-blind trial in diarrhea (2 arms), sponsored by Sun Yat-sen Memorial Hospital. Primary endpoint: Incidence of Grade >=3 Diarrhea at 6 weeks. Started Aug 2025; status: recruiting.
02
Conditions
diarrhea
Beyond the preview
Go deeper on NCT06892093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06892093.